A Comparison Between the Effect of Vaginal Sildenafil Versus Oral Estradiol Valerate on Ultrasound Parameters of Endometrial Receptivity and Follicular Growth in Iraqi Females Receiving Letrozole for Induction of Ovulation

E ndometrial thickness (ET) is one of the best predictors of implantation rate and pregnancy success rate because endometrial growth depends on hormones. Estrogen regulates the proliferative phase, endometrial proliferation induced by estrogen after menstruation is largely dependent on blood flow to the basal endometrium that produces progesterone receptors which are required for progesterone-regulated endometrial growth in the secretory process. To compare the effect of estradiol valerate vs. sildenafil citrate on endometrial receptivity and subsequent pregnancy outcome in unexplained infertility patients receiving letrozole for ovulation induction. Herein, 21 patients with unexplained infertility underwent ovulation induction by letrozole (2.5 mg). Patients were divided into 2 groups; group A (10 patients) were given sildenafil tablets vaginally (25 mg) four times daily and group B (11 patients) were treated with estradiol valerate tablet 2 mg/12 hours. Patients were evaluated by transvaginal ultrasonography (TVS) to determine endometrial thickness, pattern, size, and the number of the dominant follicles, serum assessment of Vascular Endothelial Growth Factor (VEGF) level at trigger day, and chemical pregnancy outcome 14 days later. Results showed that the endometrial thickness, patterns of the endometrium, VEGF, size of the dominant follicle at the trigger day, and pregnancy rates were not significantly different between the two groups. However, the difference in the number of the dominant follicles at trigger day was statistically significant which is more in the sildenafil treated group. The present study confirmed the findings of both Sildenafil and E 2 valerate to boost endometrial receptivity and pregnancy rate.


Introduction
Letrozole is just as effective for ovulation induction as clomiphene citrate in patients with unexplained infertility (Eskew, et al. [1] ).It is an orally active inhibitor of aromatase enzyme with strong potential for induction of ovulation.Several researchers have studied this drug as a choice to induce ovulation (Kar S, [2] ).
Aromatase enzyme inhibition causes a reduction in estrogen levels believed to result in more follicle-stimulating hormone (FSH) production, resulting in follicular growth (Requena, et al. [3] ).
Inhibitors of aromatase enzymes also cause a local increase in ovarian androgens that increases follicular sensitivity to FSH and stimulates insulin-like growth factor-1 (IGF-I) (Usluogullari, et al. [4] ).Effective implantation of an embryo in all organisms requires a receptive endometrium, good embryo quality, and synchronization of endometrial growth with embryos.
Ultrasonography markers like endometrial thickness, pattern, blood flow, and biochemical markers are often used to assess endometrial receptivity during the implantation window (Teh, et al. [5] ).A sufficiently thickened endometrium is an important factor for implantation of embryos and can predict the outcome of pregnancy with high specificity and sensitivity (Zhang, et al. [6] ).In addition, many studies recorded a strong positive association between a 7 mm (preferably > 9 mm) triple-layer thickened endometrium and pregnancy rate (Moini, et al. [7] ).
studied the effect of prolonged estradiol valerate treatment during controlled ovarian hyperstimulation cycles and found that the average endometrial thickness in the treatment group increased after treatment and also rate of pregnancy increased more than in the control group (Chen, et al. [9] ).

Sildenafil
Vaginal [ 10] ).The implantation accomplished relies on the blastocyst's capacity to invade the endometrium and create blood supply, which demands the genes to produce the proteins necessary to digest the matrix of endometrial cells, control cell growth, and provoke angiogenesis for example tumor suppressor factor (p53), plasminogen activator inhibitor 1 (PAI-1) and vascular endothelial growth factor (VEGF) (D Ly K, et al. [11] ). Sildenafil citrate significantly increased p53 and angiogenic responses with enhanced VEGF (Di X, et al. [12] ).The potential, even promising, functional markers of endometrial receptivity are invasive and expensive.Therefore, Transvaginal ultrasonography has been suggested as an alternative approach in endometrial receptivity assessment.It was reported that endometrial thickness and pattern on HCG day might be a prediction of pregnancy success (Naha, et al. [13] ).

Materials and Methods
The present study is a comparative (Zhao, et al. [14] ) as shown in Figure 1.

The endometrium thickness as shown in
Figure 2 is known as the maximum distance in the longitudinal plane of the uterus between the two endometriummyometrium junction interfaces (Fang, et al. [15] ).Also, the number and size of Graafian follicles have been measured by mean follicular diameter (mean of two orthogonal diameter measurements) reaching ≥ 17 mm.as shown in Figure 3.
Blood samples were taken from all patients for measuring the level of vascular endothelial growth factor in the serum.
Then, timed intercourse (24-36 hours after hCG injection) was advised.Three days later, the luteal phase was supported by vaginal progesterone (Cyclogest, Actavis, UK, 400 mg).After 14 days β hCG test was done in the blood to check pregnancy.

Statistical Analysis
The collected data were coded, tabulated,

Results
Twenty-one patients with primary or secondary infertility were included in the present study, all patients had normal HSG and all received letrozole as an ovulation induction drug and they all had no gynecological problem.

Demographic parameters and the basal hormonal profile
Regarding the demographic parameters (age, BMI of patients, and duration of infertility) were shown in

Comparison between endometrial thickness at the cycle's 7 th day and at the hCG trigger's day
There are no significant differences (P>0.05) between the endometrial thickness (ET) at cycle 7 th day between the studied groups also, there are no significant differences between the ET at the day of hCG trigger between the studied groups as shown in Figure 4.In contrast, there was a statistically highly significant difference between endometrial thickness at cycle 7 th day and trigger day within the estradiol group (P≤0.001).Also, there was a statistically highly significant difference between endometrial thickness at cycle 7 th day and trigger day within the sildenafil group (P≤0.001).

Comparison of Ultrasound parameter and VEGF level at the day of hCG administration
The difference in the number of the dominant follicles at hCG day between studied groups was statistically significant (P<0.05) which was more in the sildenafil group.However, the difference in the size of the dominant follicles was insignificant (P>0.05) between the studied groups.There were no significant differences (P>0.05) between sildenafil and estradiol treated groups.Regarding the mean VEGF level which was 217.2, 218.9 respectively (P>0.05) as shown in Table 3.

Pregnancy rates
The biochemical pregnancy rates were four in group 1 and one in group 2 (P>0.05) which is insignificant (Table 3).

Endometrial receptivity and pregnancy rate
In the present study, the endometrial thickness and pattern were assessed at the trigger day, which was enhanced in both estradiol and sildenafil combination with letrozole.However, the pregnancy rate did not show any substantial difference between the groups studied.Several studies have investigated the function of sildenafil citrate in improving blood flow and endometrial thickness in patients with a history of reproductive failure due to low endometrial response (Ataalla, et al. [16] ; Mangal and Mehirishi, [17] ).The present findings were identified by Ataalla, et al.  [21] ).Therefore, most of these studies further support the results of the present study.However, most of the previous work had compared estradiol or sildenafil alone with the patient's previous cycle used as control.Several studies have also been published, comparing estradiol and sildenafil to estradiol alone.

Dominant follicles count and size at the day of hCG trigger
When letrozole was used as ovulation induction, the mean number of mature follicles differed significantly; in sildenafil women, it was higher than in estradiol patients as presented in Table 3.
This result may lead to the thought that the daily for a total of five dosages.They recognized that overcome poor ovarian response by the adjuvant sildenafil during COH (Trakakis, et al. [23] ).This may be explained by the fact that the subsequent administration of vaginal sildenafil enters the uterine blood system directly at a higher concentration and then absorbed into the general circulation it dilutes out.

Conclusions
To sum up, an appropriately thick, dependent on hormones, proliferates in response to estrogen hormone which additionally induces the production of progesterone receptors.As a result, treatments for estradiol (E 2 ) are offered to infertile patients with thin endometrium, in an attempt to increase endometrial proliferation.The majority of estradiol clinical studies in patients with a thin endometrium dealt with frozen embryo transfer attempts, endometrial proliferation caused by estrogen relies primarily on blood flow to the basal .i1.r3 0 http://doi.org/10.28969/IJEIR.v1et al. , Dawood 37 with unexplained, primary, or secondary infertility.The study was approved by the ethics committee of the Institute.The patients who participate in this study had received informed consent and the details, advantages, and risks have been explained to them.The age of females included in the present study was less than 40 years (18-39 years).The exclusion criteria were as follows: female over 40 years of age, have severe endometriosis, any uterine congenital anomaly or acquired uterine cavity deformities that interfere with implantation (like Asherman Syndrome), Large submucosal intramural fibroid, estrogen therapy contraindications (e.g., history of DVT, stroke, and Benign liver disease), female who have tubal factors that may interfere with conception (unievery 12 hours from the 3 rd day for 5 days of the menstrual cycle.The patients with thin endometrium were randomly distributed into two groups.In group A, 10 patients were included and given sildenafil citrate 25 mg (Viagra, Pfizer Inc., New York, USA) vaginally every 6 hours from the 6 th day of the cycle.In group B, 11 patients were given estradiol valerate (estrofem, Novo Nordisk) 2 mg every 12 hours.Follow up by serial transvaginal sonography that was done at 7 th day of the cycle and after that 2-3 days interval according to endometrial thickness, regularity, and number, size of .i1.r3 0 http://doi.org/10.28969/IJEIR.v1et al. , Dawood 39 follicles, when at least one follicle reaches the size 17 mm or more on cycle day 11-13, then the trigger was given which was urinary HCG (5,000 IU, Pregnyl, Organon, Netherlands).Ultrasound examination have been done for assessing endometrial morphology (thickness and pattern), Endometrial pattern was classified as a triple-line pattern (consisting of a central hyperechoic line surrounded by two hypoechoic layers), or homogenous pattern (hyperechogenic endometrium).
statistically analyzed by Microsoft Excel 2016, and Statistical Package for Social Sciences (SPSS) version 22.0 was used.Data are presented as mean ± standard deviation.The groups were compared by the student's paired t-test, chi-square, and ANOVA.The degree of association between continuous variables was calculated by Pearson's correlation coefficient (r).The significance level was assumed at P<0.050.
Figure (1): Transvaginal ultrasound of the uterus in the longitudinal plane show triple line pattern CD12 citrate enhances the vasodilatory effects of NO by stopping cGMP from degrading.The basis of this research is to use sildenafil's vasodilator effect to enhance the ovarian blood flow and that is in turn increase ovarian response to stimulation in women with infertility.In one experimental research, it has been concluded that sildenafil administration can, however, insignificantly increase ovarian angiogenesis (Golkar, et al.[22]  ).Trakakis, et al. reported a case of a 37year-old woman who failed to show any follicular development during control ovarian hyperstimulation (COH) in an ICSI cycle but developed ten oocytes in a second cycle after adding sildenafil 50 mg .i1.r3 0 http://doi.org/10.28969/IJEIR.v1et al. , Dawood 46 endometrial pattern is important for embryo implantation and pregnancy continuation.Both estradiol and sildenafil may be used to improve the endometrium (thickness and vascularity) and to promote embryo development.Sildenafil has increased the dominant follicle counts in patients experiencing a stimulated cycle compared to estradiol valerate.This can be explained by the increase in the blood flow of the total female genital tract along

Table ( 3
): Comparison of ultrasound finding and VEGF between studied groups